PT868174E - Formulacao de capsula de gel oral de oxidos de 1,2,4-benzotriazina - Google Patents

Formulacao de capsula de gel oral de oxidos de 1,2,4-benzotriazina

Info

Publication number
PT868174E
PT868174E PT96928255T PT96928255T PT868174E PT 868174 E PT868174 E PT 868174E PT 96928255 T PT96928255 T PT 96928255T PT 96928255 T PT96928255 T PT 96928255T PT 868174 E PT868174 E PT 868174E
Authority
PT
Portugal
Prior art keywords
oxidal
benzotriazin
oral
formulation
gel capsule
Prior art date
Application number
PT96928255T
Other languages
English (en)
Inventor
Stephen Brown
Ross Blundell
Original Assignee
Sanofi Synthelabo Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo Inc filed Critical Sanofi Synthelabo Inc
Publication of PT868174E publication Critical patent/PT868174E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT96928255T 1995-09-12 1996-08-21 Formulacao de capsula de gel oral de oxidos de 1,2,4-benzotriazina PT868174E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/527,233 US5597582A (en) 1995-09-12 1995-09-12 Oral gel capsule formulation of 1,2,4-benzotriazine oxides

Publications (1)

Publication Number Publication Date
PT868174E true PT868174E (pt) 2003-04-30

Family

ID=24100665

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96928255T PT868174E (pt) 1995-09-12 1996-08-21 Formulacao de capsula de gel oral de oxidos de 1,2,4-benzotriazina

Country Status (19)

Country Link
US (1) US5597582A (pt)
EP (1) EP0868174B1 (pt)
JP (1) JPH11513365A (pt)
KR (1) KR100475388B1 (pt)
CN (1) CN1080113C (pt)
AT (1) ATE227982T1 (pt)
AU (1) AU702550B2 (pt)
CA (1) CA2231545C (pt)
CZ (1) CZ289733B6 (pt)
DE (1) DE69624935T2 (pt)
DK (1) DK0868174T3 (pt)
ES (1) ES2187668T3 (pt)
HK (1) HK1016889A1 (pt)
HU (1) HUP9802605A3 (pt)
MX (1) MX9801930A (pt)
NO (1) NO320019B1 (pt)
NZ (1) NZ315964A (pt)
PT (1) PT868174E (pt)
WO (1) WO1997009968A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5484612A (en) * 1993-09-22 1996-01-16 The Board Of Trustees Of The Leland Stanford Junior University Method of treating a mammal having a solid tumor susceptible to treatment with cisplatin
US6365181B1 (en) 2000-04-20 2002-04-02 Gattefosse Corporation Thixatropic gelatin carrier composition
CA2456569A1 (en) * 2003-03-14 2004-09-14 Auckland Uniservices Limited Benzoazine mono-n-oxides and benzoazine 1,4 dioxides and compositions therefrom for the therapeutic use in cancer treatments
US8642079B2 (en) * 2004-02-23 2014-02-04 Hormos Medical Corporation Solid formulations of ospemifene
US8758821B2 (en) * 2004-05-04 2014-06-24 Hormos Medical Ltd. Oral formulations of ospemifene
SI2275098T1 (sl) * 2004-05-04 2012-12-31 Hormos Medical Ltd. Nove oralne formulacije ospemifena
CN104705772B (zh) * 2015-01-28 2016-09-14 汤臣倍健股份有限公司 一种改善软胶囊漏油的生产工艺

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60239418A (ja) * 1984-05-15 1985-11-28 Nippon Kayaku Co Ltd エトポシド軟カプセル製剤
US5175287A (en) * 1986-09-25 1992-12-29 S R I International Process for preparing 1,2,4-benzotriazine oxides
DE4322826A1 (de) * 1993-07-08 1995-01-12 Galenik Labor Freiburg Gmbh Pharmazeutisches Präparat
US5484612A (en) * 1993-09-22 1996-01-16 The Board Of Trustees Of The Leland Stanford Junior University Method of treating a mammal having a solid tumor susceptible to treatment with cisplatin
WO1996037192A1 (en) * 1995-05-26 1996-11-28 Vesifact Ag Pharmaceutical and cosmetic compositions containing sphingo- and glycolipids
US5637085A (en) * 1995-11-20 1997-06-10 Cardinale; Robert M. Method of cancer tumor treatment by slow release delivery of 1,2,4-benzotriazine oxides to tumor site

Also Published As

Publication number Publication date
CA2231545A1 (en) 1997-03-20
DE69624935T2 (de) 2003-03-27
MX9801930A (es) 1998-10-31
AU6780096A (en) 1997-04-01
CN1200669A (zh) 1998-12-02
DK0868174T3 (da) 2003-03-17
KR19990044573A (ko) 1999-06-25
NZ315964A (en) 1999-03-29
DE69624935D1 (de) 2003-01-02
WO1997009968A1 (en) 1997-03-20
NO320019B1 (no) 2005-10-10
EP0868174B1 (en) 2002-11-20
CZ289733B6 (cs) 2002-03-13
HK1016889A1 (en) 1999-11-12
KR100475388B1 (ko) 2005-08-05
EP0868174A4 (pt) 1998-10-07
HUP9802605A3 (en) 2000-02-28
JPH11513365A (ja) 1999-11-16
AU702550B2 (en) 1999-02-25
ES2187668T3 (es) 2003-06-16
NO981042L (no) 1998-03-10
CA2231545C (en) 2008-07-15
US5597582A (en) 1997-01-28
HUP9802605A2 (hu) 1999-04-28
CZ64498A3 (cs) 1998-08-12
EP0868174A1 (en) 1998-10-07
NO981042D0 (no) 1998-03-10
CN1080113C (zh) 2002-03-06
ATE227982T1 (de) 2002-12-15

Similar Documents

Publication Publication Date Title
DE68905224T2 (de) Transendoskopische implantatkapsel.
ITRM940613A0 (it) Capsula di gelatina morbida e relativo procedimento ed apparecchio di preparazione
CA2109623A1 (en) Process for solubilizing difficultly soluble pharmaceutical actives
NO167384C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-aralkylpiperidinmethanolderivater.
ZA9511034B (en) Soft gelatin pharmaceutical dosage form
AU3811089A (en) Chewable, edible soft gelatin capsule
ATE200620T1 (de) Duloxetin enthaltende darmlösliche pellets
ATE98480T1 (de) Arzneimittelformulierungen.
NO901684D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater.
IL112664A0 (en) 4-amino derivatives of mycophenolic acid, their preparation and pharmaceutical compositions containing them
BR9407178A (pt) Cápsula de gelatina
DE69525019D1 (de) Cyclosporin enthaltende Weichkapselzusammensetzungen
IL112667A0 (en) 6-substituted derivatives of mycophenolic acid, their preparation and pharmaceutical compositions containing them
GB9603571D0 (en) Soft gelatin capsules
DE69711267D1 (de) Cyclosporin enthaltende Weichkapselpräparate
FI941447A0 (fi) Suun kautta annettavat, kapseleina olevat ubidekarenonivalmisteet
PT868174E (pt) Formulacao de capsula de gel oral de oxidos de 1,2,4-benzotriazina
PL324690A1 (en) Improved therapeutic agents
ITBO980276A0 (it) Unita' orientatrice ed alimentatrice di fondelli per capsule medicinal i.
NO881768D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner.
NO905327L (no) Fremgangsmaate for fremstilling av terapeutisk aktive karbamoylderivater.
IT8720438A0 (it) Esteri di 1,4:3,6-dianidrosorbitolo-2-mononitrato e 5-mononitrato, loro procedimento di preparazione e loro composizioni farmaceutiche.
DE68906245T2 (de) Therapeutisches Mittel gegen Aids.
IT1280366B1 (it) Selezionatore di capsule mal riempite
IL131703A0 (en) Pharmaceutical compositions in the form of soft gelatine capsule containing cyclosporin